<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Testing amniotic fluid for assessment of fetal lung maturity</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Testing amniotic fluid for assessment of fetal lung maturity</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Testing amniotic fluid for assessment of fetal lung maturity</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Gillen-Goldstein, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew P MacKenzie, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edmund F Funai, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 22, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The pulmonary system is among the last of the fetal organ systems to mature, both functionally and structurally. Fetal sex appears to play a role in this process; respiratory problems near term are slightly more common among male compared with female fetuses [<a href="#rid1">1-3</a>].</p><p>Because the immature pulmonary system may not oxygenate the preterm neonate adequately, preterm birth can lead to significant neonatal morbidity or mortality. Laboratory tests can be performed on amniotic fluid before iatrogenic preterm birth to provide an indirect assessment of the likelihood of lung maturity (direct tests of fetal lung function are not possible), and can be a factor in planning the time of induction or cesarean birth. Although once commonly performed, fetal lung maturity testing is no longer available in many countries.</p><p>This topic will discuss testing of amniotic fluid for assessment of fetal lung maturity. Clinical manifestations, diagnosis, treatment, sequelae, and prevention of neonatal pulmonary immaturity are reviewed separately. (See  <a class="medical medical_review" href="/d/html/5055.html" rel="external">"Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4997.html" rel="external">"Respiratory distress syndrome (RDS) in preterm infants: Management"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">WHEN IS FETAL LUNG MATURITY TESTING PERFORMED?</span><span class="headingEndMark"> — </span>In most clinical settings, testing for fetal lung maturity is not performed because (1) delaying delivery because of lung immaturity would place the pregnant patient or fetus at significant risk, or (2) the fetus would benefit from delaying delivery, even if lung maturity is documented, and delaying delivery does not place the pregnant patient at significant risk, or (3) a course of antenatal corticosteroids can be given, which will benefit the fetus with immature lungs and has no proven harms [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery"</a>.)</p><p>These assessments may be ambiguous, so information about lung maturity sometimes may be helpful in the balance [<a href="#rid5">5</a>]. The information may also be helpful in estimating the level of newborn care that will be required. Thus, a test for fetal lung maturity may be performed before semielective but medically indicated births &lt;39 weeks when this information significantly impacts assessment of the balance between the maternal-fetal risks of continuing the pregnancy versus the maternal-fetal risks of preterm birth, but this is an infrequent occurrence. In the United States, testing for fetal lung maturity is now rarely performed, and there is no clinical scenario where it is required.</p><p class="headingAnchor" id="H967242218"><span class="h2">When should testing be avoided?</span></p><p class="bulletIndent1"><span class="glyph">●</span>Tests for fetal lung maturity are generally <strong>not</strong> performed before 32 weeks of gestation, given the high prevalence of fetal pulmonary immaturity and the lower predictive value of a mature test result at this gestational age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tests for fetal lung maturity are <strong>not</strong> performed in pregnancies with a reliable gestational age ≥39 weeks. At this gestational age, fetal lung maturity can be inferred; test results are not more predictive of respiratory outcome than gestational age alone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Suboptimal gestational age assessment is <strong>not</strong> a good reason to perform a test for fetal lung maturity. The American College of Obstetricians and Gynecologists (ACOG) considers gestational age assessment unreliable (ie, suboptimally dated pregnancy) if no ultrasound examination was performed before 22+0 weeks of gestation confirming or revising the estimated due date [<a href="#rid6">6</a>]. ACOG recommends <strong>not </strong>performing amniocentesis for fetal lung maturity testing in suboptimally dated pregnancies to guide timing of delivery as this decision should be based on the best clinical estimate of gestational age and standard indications for intervention rather than results from fetal lung maturity testing [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fetal lung maturity testing is <strong>not</strong> performed to justify a planned repeat cesarean birth or labor induction for patient convenience at 37 or 38 weeks of gestation rather than at ≥39 weeks. Even when lung maturity test results suggest a low risk of respiratory problems, neonates delivered at 37 or 38 weeks are at higher risk of adverse outcome than those delivered at 39 to 40 weeks of gestation without fetal lung maturity testing [<a href="#rid7">7,8</a>]. A fetal lung maturity test consistent with maturity is not an appropriate indication for early delivery in the absence of appropriate clinical indications [<a href="#rid9">9</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h1">FETAL MATURITY TESTS</span></p><p class="headingAnchor" id="H4190227888"><span class="h2">Overview</span><span class="headingEndMark"> — </span>Fetal lung maturity is evaluated by biochemical tests or biophysical tests. Biochemical tests measure the concentration of particular components of pulmonary surfactant. Biophysical tests evaluate the surface-active effects of these phospholipids.</p><p>The choice of test  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>) should be based upon availability, presence or absence of contaminants (see <a class="local">'Blood, meconium'</a> below), and clinician preference. Although randomized trials comparing multiple tests have not been performed, controlled studies suggest that no test in table 1 performed significantly better than the others [<a href="#rid4">4,10-13</a>]. All are better at predicting the absence, rather than the presence, of respiratory distress. All perform less well at earlier gestational ages, which should be taken into account when interpreting results.</p><p>If the first test performed on an amniotic fluid sample is immature, we suggest not performing a second different test on the same sample, as medicolegal issues may arise if the neonate is delivered after discordant results and develops respiratory problems.</p><p class="headingAnchor" id="H2020802424"><span class="h2">Availability</span><span class="headingEndMark"> — </span>The lamellar body count is the only commercially available test for assessing fetal lung maturity in the United States. The other tests described below are no longer available in commercial laboratories but may be available in some hospital laboratories. Some of these may also be available in other parts of the world.</p><p class="headingAnchor" id="H1608546091"><span class="h2">Lamellar body count</span><span class="headingEndMark"> — </span>Lamellar body counts are a direct measurement of surfactant production by type-II pneumocytes. A standard hematology analyzer (eg, Coulter LH 750, Coulter Ac.T diff, Sysmex XE-2100) can be used for quantification because of the similar size of lamellar bodies and platelets. Values less than 15,000 per microliter are almost always associated with lung immaturity; values ≥50,000 per microliter strongly suggest lung maturity [<a href="#rid14">14-16</a>]. However, there is no consensus on the optimal threshold for predicting lung maturity; values greater than 30,000 to 40,000 per microliter, as well as higher levels, have been suggested  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>) [<a href="#rid17">17-19</a>]. As with all tests of fetal lung maturity, gestational age affects the positive predictive value (see <a class="local">'Gestational age'</a> below). Gestational-age specific lamellar body count cutoffs for risk assessment of fetal lung maturity are available [<a href="#rid13">13,20</a>].</p><p>The lamellar body count has been used as an initial screening test, followed by the lecithin/sphingomyelin ratio where available when the lamellar body count is neither clearly mature (≥50,000 per microliter) nor immature (&lt;30,000 per microliter).</p><p>Compared with thin-layer chromatography techniques, the lamellar body count is faster, more objective, less labor intensive, less technique dependent, and less expensive [<a href="#rid10">10</a>]. In meta-analyses, the lamellar body count performed as well or slightly better than the lecithin/sphingomyelin ratio in predicting respiratory distress [<a href="#rid21">21,22</a>]. The lamellar body count performs as well as the formerly available TDx-FLM II (see <a class="local">'Surfactant/albumin ratio'</a> below); both perform best when interpreted according to gestational age [<a href="#rid13">13</a>].</p><p>Blood contamination can lead to false elevation of the lamellar body count because platelets are counted as lamellar bodies; the effect of meconium is minimal.</p><p>All laboratories need to establish their own cutoffs for lamellar body count since hematology analyzers vary in sensitivity and gain settings. Establishing internal quality control is also important for this test. The Clinical and Laboratory Standards Institute (CLSI) provides guidance for the use of automated cell counting to count lamellar bodies in amniotic fluid. The document "Assessment of Fetal Lung Maturity by the Lamellar Body Count (C58)" provides guidelines for the use of automated cell counting to perform lamellar body counts, describes methods to assist in test verification and validation, and describes methods to select an appropriate maturity cutoff. Although C58 is no longer being reviewed through the CLSI Consensus Document Development Process, the document was technically valid of as July 2020 and is still available <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fclsi.org%2Fstandards%2Fproducts%2Fclinical-chemistry-and-toxicology%2Fdocuments%2Fc58%2F&amp;token=QQEGvThDHj%2BjMBZVfljHISypJQb%2BSW2QPHzmKgmiyNJZ2CStL%2FBnAbj93bY18ihwF99D4sW53wkYYdY6lbM%2FTmt16vZDsZbB%2BvNHJJJd3WA%3D&amp;TOPIC_ID=405" target="_blank">online</a> because of its value to the laboratory community.</p><p class="headingAnchor" id="H8"><span class="h2">Phosphatidylglycerol</span><span class="headingEndMark"> — </span>Phosphatidylglycerol (PG) is a minor constituent of surfactant. It begins to increase appreciably in amniotic fluid after 35 weeks, several weeks after the rise in lecithin [<a href="#rid23">23</a>]. Because PG enhances the spread of phospholipids in the alveoli, its presence indicates an advanced state of fetal lung development and function.</p><p>PG testing can be performed by thin-layer chromatography, so it can be determined alone or in conjunction with testing for the lecithin/sphingomyelin ratio. It may be reported qualitatively as positive or negative, where positive represents an exceedingly low risk of respiratory distress, or quantitatively, where a thin-layer chromatography value &gt;2 percent is associated with a minimal rate of respiratory distress  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>)[<a href="#rid24">24</a>].</p><p>Because thin-layer chromatography is a complicated and time-consuming technique, a rapid, semiquantitative immunologic slide agglutination test (AmnioStat-FLM) and several enzymatic assays were developed and have been validated as acceptable alternative techniques [<a href="#rid25">25-28</a>]. The slide agglutination test is the most common method for testing for PG; however, it appears to be less sensitive for detecting fetal lung maturity than thin-layer chromatography [<a href="#rid29">29</a>].</p><p>An advantage of testing for PG is that blood or meconium usually does not affect test results [<a href="#rid4">4</a>]. A disadvantage is that the absence of PG, especially before 36 weeks of gestation, is less predictive of the occurrence of respiratory distress than immature results from other tests.</p><p class="headingAnchor" id="H1700429375"><span class="h2">Lecithin/sphingomyelin ratio</span><span class="headingEndMark"> — </span>The lecithin/sphingomyelin ratio is based upon the observation that there is outward flow of lung secretions from the lungs into the amniotic fluid. This process changes the phospholipid composition of amniotic fluid, thereby enabling indirect assessment of fetal lung maturity through evaluation of this fluid.</p><p>The concentrations of lecithin and sphingomyelin in amniotic fluid are approximately equal until 32 to 33 weeks of gestation, at which time the concentration of lecithin begins to increase significantly while the sphingomyelin concentration remains approximately the same. The measurement of sphingomyelin serves as a constant comparison for control of the relative increases in lecithin because the volume of amniotic fluid cannot be accurately measured clinically.</p><p>Determining the lecithin/sphingomyelin ratio involves thin-layer chromatography after organic solvent extraction. It is a technically difficult test to perform and interpret; care at each step of sample handling is critical for consistent results [<a href="#rid30">30</a>]. The sample should be kept on ice or refrigerated if transport to a laboratory is required (most laboratories cannot perform this test). Improper storage conditions can change the lecithin/sphingomyelin ratio since amniotic fluid contains enzymes that can be affected by temperature [<a href="#rid31">31</a>]. The amniotic fluid sample must be well mixed before testing. It takes several hours to perform the test and may take 24 hours when both transport and testing time are considered, which is another disadvantage of this method.</p><p>Individual laboratories should calculate a threshold value for predicting lung maturity by correlating their test results with clinical outcome as the variation within and between laboratories can be considerable. Empirically, the risk of respiratory distress is exceedingly low when the lecithin/sphingomyelin ratio is greater than 2.0  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>) [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H1159561295"><span class="h2">Optical density at 650 nm</span><span class="headingEndMark"> — </span>An indirect measurement of lamellar bodies can be obtained by measuring the optical density of amniotic fluid at a wavelength of 650 nanometers. It is based upon the concept that increasing opalescence is due to increasing numbers of lamellar bodies. An optical density reading ≥0.15 is used as the indicator of lung maturity [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H2888059142"><span class="h2">Foam stability index</span><span class="headingEndMark"> — </span>The foam stability index (FSI) assesses total surfactant activity. It is a rapid predictor of fetal lung maturity based upon the ability of surfactant to generate stable foam in the presence of ethanol [<a href="#rid34">34</a>]. Ethanol is added to a sample of amniotic fluid to eliminate the effects of nonsurfactant factors on foam formation. The mixture is then shaken and will generate a stable ring of foam if surfactant is present. The FSI is calculated by utilizing serial dilutions of ethanol to quantitate the amount of surfactant present [<a href="#rid35">35</a>].</p><p>Amniotic fluid samples for FSI should not be collected in silicone tubes, as the silicone will produce "false foam." The discriminating value indicative of lung maturity is usually set at ≥47. A positive result virtually excludes the risk of respiratory distress; however, a negative test often occurs with mature lungs [<a href="#rid36">36</a>]. The presence of blood or meconium interferes with results of the FSI.</p><p class="headingAnchor" id="H23142545"><span class="h2">Surfactant/albumin ratio</span><span class="headingEndMark"> — </span>The surfactant/albumin ratio also assesses total surfactant activity. The TDx-FLM II was the commercially available test for measuring the surfactant/albumin ratio, but the manufacturer retired the analytical systems for TDx-FLM II testing and ended production of the reagent required to perform it.</p><p>TDx-FLM II was based on the principle of fluorescence polarization and used an automated analyzer to quantitate the competitive binding of a fluorescent probe to both surfactant and albumin in a sample of amniotic fluid; thus, it was a true direct measurement of surfactant concentration [<a href="#rid37">37</a>]. An elevated surfactant/albumin ratio correlated with fetal lung maturity; the threshold for maturity was 55 mg of surfactant per gram albumin [<a href="#rid38">38</a>]. Test performance compared favorably with the well-established lecithin/sphingomyelin ratio and PG tests  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>) and was gestational-age dependent  (<a class="graphic graphic_table graphicRef72799" href="/d/graphic/72799.html" rel="external">table 2</a>) [<a href="#rid12">12,39,40</a>].</p><p>The advantage of the TDx-FLM II was that it was a simple, automated, rapid test that varied minimally between laboratories and required only a small volume of amniotic fluid [<a href="#rid4">4</a>]. A disadvantage was the wide indeterminate range: Values greater than 55 were considered mature, values less than 40 were considered immature, while values of 40 to 54 were considered "indeterminate" [<a href="#rid4">4,39</a>]. Blood or meconium in the amniotic fluid also affected results.</p><p class="headingAnchor" id="H11"><span class="h1">FACTORS THAT MAY AFFECT INTERPRETATION</span></p><p class="headingAnchor" id="H12"><span class="h2">Gestational age</span><span class="headingEndMark"> — </span>For each test, the ability to predict respiratory distress is influenced by the prevalence of respiratory distress in the population tested; thus, the predictive value varies with gestational age [<a href="#rid13">13,41,42</a>]. For example, in one analysis, the risk of respiratory distress after a TDx-FLM II of 60 mg/g at 29 and 37 weeks of gestation was 16 and 1 percent, respectively [<a href="#rid41">41</a>]. In another analysis, the risk of respiratory distress after a lamellar body count of 60,000 per microliter at 32 and 37 weeks of gestation was 11 and 1.2 percent, respectively [<a href="#rid20">20</a>].</p><p>Gestational age is an important factor for predicting readiness for neonatal life and absence of neonatal morbidity, even when fetal lung maturity is documented prenatally. In a retrospective cohort study of neonatal outcomes of newborns with mature fetal lung indices, the rate of composite, adverse neonatal outcome with delivery at 34+0 to 36+6 weeks, 37+0 to 38+6 weeks, and ≥39 weeks was 21, 13, and 4 percent, respectively [<a href="#rid43">43</a>]. In a study that compared outcomes of early-term births after positive fetal lung maturity testing (n = 180) with full-term births (n = 47,957), the primary composite outcome (death, ventilator for ≥2 days, continuous positive airway pressure, proven sepsis, pneumonia or meningitis, treated hypoglycemia, hyperbilirubinemia [phototherapy], five minute Apgar &lt;7) was approximately fourfold higher in the early-term births [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Blood, meconium</span><span class="headingEndMark"> — </span>Phosphatidylglycerol (PG) determination generally is not affected by blood, meconium, or other contaminants; its ability to predict lung maturity is the same whether or not contamination is present [<a href="#rid33">33</a>]. This is an advantage for assessing fetal lung maturity status since these substances are commonly found in amniotic fluid.</p><p>The surfactant/albumin ratio is usually reliable if mature since contaminants tend to cause falsely immature findings, although the degree and direction of interference are not well defined [<a href="#rid44">44-48</a>].</p><p>By contrast, the presence of blood or meconium can interfere with interpretation of the lecithin/sphingomyelin ratio [<a href="#rid49">49</a>]. Bloody samples give false information because blood contains sphingomyelin and decreases extraction of lecithin by cold acetone techniques (falsely low "L" and falsely high "S") [<a href="#rid50">50</a>]. Therefore, if blood or other particulate matter is present in the amniotic fluid sample, a low-speed, short centrifugation should be used to remove the cellular component [<a href="#rid30">30</a>]; however, this does not guarantee an accurate result, especially when there is a lot of blood or meconium.</p><p class="headingAnchor" id="H14"><span class="h2">Oligohydramnios and polyhydramnios</span><span class="headingEndMark"> — </span>The effect of amniotic fluid volume (oligohydramnios, polyhydramnios) on test results has not been studied extensively [<a href="#rid51">51,52</a>]. Theoretically, tests that are expressed as a ratio or proportion of two solutes released into the amniotic fluid should remain accurate independent of amniotic fluid volume, while tests that reflect the concentration of a substance in the amniotic fluid (eg, lamellar body count, PG) may be affected by amniotic fluid volume.</p><p class="headingAnchor" id="H15"><span class="h2">Vaginal pool samples</span><span class="headingEndMark"> — </span>In pregnant patients with intact membranes, amniotic fluid is obtained by amniocentesis. (See  <a class="medical medical_review" href="/d/html/5390.html" rel="external">"Diagnostic amniocentesis", section on 'Third-trimester amniocentesis'</a>.)</p><p>In pregnant patients with ruptured membranes, a syringe can be used to aspirate amniotic fluid pooled in the posterior vaginal fornix. Vaginal pool specimens can also be collected using a sterile sponge.</p><p>However, the lecithin/sphingomyelin ratio can be higher in the vaginal pool than in fluid obtained by amniocentesis [<a href="#rid53">53</a>], and false-positive PG have been reported in vaginal pool samples due to bacterial contamination [<a href="#rid54">54,55</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Antenatal corticosteroids</span><span class="headingEndMark"> — </span>Standard tests for predicting fetal lung maturity may be less reliable for predicting absence of fetal lung maturity in patients who have received a course of antenatal corticosteroids to enhance fetal lung maturation. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery"</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Maternal diabetes mellitus</span><span class="headingEndMark"> — </span>Most experts use the same threshold value for lung maturity for pregnant people with and without diabetes (preexisting [pregestational] or gestational diabetes) [<a href="#rid56">56-60</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Twin pregnancy</span><span class="headingEndMark"> — </span>If amniocentesis to determine fetal lung maturity is performed, some authors believe that amniocentesis of only one twin is adequate if the gestation is ≥36 weeks [<a href="#rid61">61,62</a>], but others test both twins in all cases because pulmonary maturity can be asynchronous [<a href="#rid63">63</a>]. When only one sac is sampled, it is reasonable to sample the sac of the fetus less likely to be mature. As an example, a larger, nonpresenting male fetus would be less likely to have achieved lung maturity than a smaller, presenting female fetus.</p><p class="headingAnchor" id="H592519123"><span class="h1">ALTERNATIVES TO TESTING AMNIOTIC FLUID</span><span class="headingEndMark"> — </span>Quantitative ultrasound fetal lung maturity assessment, Doppler assessment, and magnetic resonance imaging (MRI) are some of the investigative techniques used for noninvasive assessment of fetal lung maturity in pilot studies [<a href="#rid64">64-70</a>]. None of these techniques is appropriate for clinical use.</p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Fetal lung maturity testing before delivery is rarely performed. It is not useful as a component of delivery timing decision-making in pregnancies with well-documented gestational age ≥39 weeks (because lung maturity is likely), pregnancies less than 32 weeks of gestation (because lung immaturity is likely), and when delivery is obstetrically/medically indicated (because delaying delivery will place the pregnant patient or fetus at significant risk). If a pregnancy is suboptimally dated (no ultrasound examination before 22+0<sup> </sup>weeks), timing of delivery should be based on the best clinical estimate of gestational age and standard indications for intervention; fetal lung maturity testing is not recommended as a component of decision-making. (See <a class="local">'When is fetal lung maturity testing performed?'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – A test for fetal lung maturity may be performed before semielective but medically indicated births &lt;39 weeks when this information significantly impacts assessment of the balance between the maternal-fetal risks of continuing the pregnancy versus the maternal-fetal risks of preterm birth. This is an infrequent occurrence. (See <a class="local">'When is fetal lung maturity testing performed?'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Testing</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal lung maturity can be assessed by testing for components of fetal lung secretions in amniotic fluid. No test performs significantly better than another, and all are better at predicting the absence, rather than the presence, of respiratory distress. (See <a class="local">'Fetal maturity tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The choice of test should be based upon availability, presence or absence of contaminants, and physician preference. A summary of the different tests available and the assets and liabilities associated with each is shown in the table  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>). The lamellar body count is the test generally used for assessing fetal lung maturity in the United States. The other tests in the table are no longer available in commercial laboratories, but may be available in some hospital laboratories. (See <a class="local">'Fetal maturity tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest performing only one test for fetal lung maturity on an amniotic fluid sample. (See <a class="local">'Fetal maturity tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interpretation</strong> – Gestational age is an important factor in interpreting tests of fetal lung maturity. All tests perform less well at earlier gestational ages, which should be taken into account when interpreting results. Gestational age-specific tables for prediction of respiratory distress have been published. (See <a class="local">'Gestational age'</a> above.)</p><p></p><p class="bulletIndent1">Blood or meconium in amniotic fluid affects some test results  (<a class="graphic graphic_table graphicRef64274" href="/d/graphic/64274.html" rel="external">table 1</a>). Oligohydramnios, polyhydramnios, and source of amniotic fluid (vaginal pool versus amniocentesis) can also affect results. The same threshold value for lung maturity can be used for both nondiabetic and diabetic patients (pregestational or gestational diabetes). (See <a class="local">'Factors that may affect interpretation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Anadkat JS, Kuzniewicz MW, Chaudhari BP, et al. Increased risk for respiratory distress among white, male, late preterm and term infants. J Perinatol 2012; 32:780.</a></li><li><a class="nounderline abstract_t">Dani C, Reali MF, Bertini G, et al. Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. Eur Respir J 1999; 14:155.</a></li><li><a class="nounderline abstract_t">Condò V, Cipriani S, Colnaghi M, et al. Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants? J Matern Fetal Neonatal Med 2017; 30:1267.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 97: Fetal lung maturity. Obstet Gynecol 2008; 112:717.</a></li><li><a class="nounderline abstract_t">Towers CV, Freeman RK, Nageotte MP, et al. The case for amniocentesis for fetal lung maturity in late-preterm and early-term gestations. Am J Obstet Gynecol 2014; 210:95.</a></li><li><a class="nounderline abstract_t">Committee on Obstetric Practice. Committee Opinion No. 688: Management of Suboptimally Dated Pregnancies. Obstet Gynecol 2017; 129:e29. Reaffirmed 2019.</a></li><li><a class="nounderline abstract_t">Bates E, Rouse DJ, Mann ML, et al. Neonatal outcomes after demonstrated fetal lung maturity before 39 weeks of gestation. Obstet Gynecol 2010; 116:1288.</a></li><li><a class="nounderline abstract_t">Tita ATN, Jablonski KA, Bailit JL, et al. Neonatal outcomes of elective early-term births after demonstrated fetal lung maturity. Am J Obstet Gynecol 2018; 219:296.e1.</a></li><li><a class="nounderline abstract_t">ACOG Committee on Practice Bulletins -- Obstetrics. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol 2009; 114:386. Reaffirmed 2020.</a></li><li><a class="nounderline abstract_t">Neerhof MG, Haney EI, Silver RK, et al. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol 2001; 97:305.</a></li><li><a class="nounderline abstract_t">Winn-McMillan T, Karon BS. Comparison of the TDx-FLM II and lecithin to sphingomyelin ratio assays in predicting fetal lung maturity. Am J Obstet Gynecol 2005; 193:778.</a></li><li><a class="nounderline abstract_t">Haymond S, Luzzi VI, Parvin CA, Gronowski AM. A direct comparison between lamellar body counts and fluorescent polarization methods for predicting respiratory distress syndrome. Am J Clin Pathol 2006; 126:894.</a></li><li><a class="nounderline abstract_t">Karcher R, Sykes E, Batton D, et al. Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid. Am J Obstet Gynecol 2005; 193:1680.</a></li><li><a class="nounderline abstract_t">Neerhof MG, Dohnal JC, Ashwood ER, et al. Lamellar body counts: a consensus on protocol. Obstet Gynecol 2001; 97:318.</a></li><li><a class="nounderline abstract_t">Ventolini G, Neiger R, Hood DL, Belcastro MR. Changes in the threshold of fetal lung maturity testing and neonatal outcome of infants delivered electively before 39 weeks gestation: implications and cost-effectiveness. J Perinatol 2006; 26:264.</a></li><li><a class="nounderline abstract_t">Khazardoost S, Yahyazadeh H, Borna S, et al. Amniotic fluid lamellar body count and its sensitivity and specificity in evaluating of fetal lung maturity. J Obstet Gynaecol 2005; 25:257.</a></li><li><a class="nounderline abstract_t">Dalence CR, Bowie LJ, Dohnal JC, et al. Amniotic fluid lamellar body count: a rapid and reliable fetal lung maturity test. Obstet Gynecol 1995; 86:235.</a></li><li><a class="nounderline abstract_t">Ghidini A, Poggi SH, Spong CY, et al. Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non-diabetic pregnant women. Arch Gynecol Obstet 2005; 271:325.</a></li><li><a class="nounderline abstract_t">Janicki MB, Dries LM, Egan JF, Zelop CM. Determining a cutoff for fetal lung maturity with lamellar body count testing. J Matern Fetal Neonatal Med 2009; 22:419.</a></li><li><a class="nounderline abstract_t">Zhao Q, Zhao Z, Leung-Pineda V, et al. Predicting respiratory distress syndrome using gestational age and lamellar body count. Clin Biochem 2013; 46:1228.</a></li><li><a class="nounderline abstract_t">Wijnberger LD, Huisjes AJ, Voorbij HA, et al. The accuracy of lamellar body count and lecithin/sphingomyelin ratio in the prediction of neonatal respiratory distress syndrome: a meta-analysis. BJOG 2001; 108:583.</a></li><li><a class="nounderline abstract_t">Besnard AE, Wirjosoekarto SA, Broeze KA, et al. Lecithin/sphingomyelin ratio and lamellar body count for fetal lung maturity: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2013; 169:177.</a></li><li><a class="nounderline abstract_t">Hallman M, Kulovich M, Kirkpatrick E, et al. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976; 125:613.</a></li><li><a class="nounderline abstract_t">Grenache DG, Gronowski AM. Fetal lung maturity. Clin Biochem 2006; 39:1.</a></li><li><a class="nounderline abstract_t">Coapman-Hankin RA, Kiechle FL, Epstein E, et al. Three methods compared for determining phosphatidylglycerol in amniotic fluid. Clin Chem 1985; 31:1374.</a></li><li><a class="nounderline abstract_t">Halvorsen PR, Gross TL. Laboratory and clinical evaluation of a rapid slide agglutination test for phosphatidylglycerol. Am J Obstet Gynecol 1985; 151:1061.</a></li><li><a class="nounderline abstract_t">Eisenbrey AB, Epstein E, Zak B, et al. Phosphatidylglycerol in amniotic fluid. Comparison of an "ultrasensitive" immunologic assay with TLC and enzymatic assay. Am J Clin Pathol 1989; 91:293.</a></li><li><a class="nounderline abstract_t">Lockitch G, Wittmann BK, Mura SM, Hawkley LC. Evaluation of the Amniostat-FLM assay for assessment of fetal lung maturity. Clin Chem 1984; 30:1233.</a></li><li><a class="nounderline abstract_t">Knight JA, Miya T, Wu JT. Standard lecithin/sphingomyelin and phosphatidylglycerol techniques compared with immunologic slide test. Obstet Gynecol 1985; 65:840.</a></li><li><a class="nounderline abstract_t">Ashwood ER. Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem 1997; 43:211.</a></li><li class="breakAll">Whitsett JA, Pryhuber GS, Rice WR. Acute respiratory disorders. In: Neonatology pathophysiology and the management of the newborn, Avery GB, Fletcher MA, MacDonald MG (Eds), JB Lippincott, Philadelphia 1994. p.429.</li><li><a class="nounderline abstract_t">Gluck L, Kulovich MV, Borer RC Jr, Keidel WN. The interpretation and significance of the lecithin-sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120:142.</a></li><li><a class="nounderline abstract_t">Dubin SB. The laboratory assessment of fetal lung maturity. Am J Clin Pathol 1992; 97:836.</a></li><li><a class="nounderline abstract_t">Clements JA, Platzker AC, Tierney DF, et al. Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med 1972; 286:1077.</a></li><li><a class="nounderline abstract_t">Sher G, Statland BE, Freer DE, Kraybill EN. Assessing fetal lung maturation by the foam stability index test. Obstet Gynecol 1978; 52:673.</a></li><li class="breakAll">Jobe AH. Fetal lung development, tests for maturation, induction of maturation and treatment. In: Maternal-Fetal Medicine, Creasy RK, Resnik R (Eds), WB Saunders, Philadelphia 1999. p.418.</li><li><a class="nounderline abstract_t">Bernstein LH, Stiller R, Menzies C, et al. Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed. Yale J Biol Med 1995; 68:101.</a></li><li class="breakAll">Standards of Laboratory Practice: Guidelines for the Evaluation and Management of the Newborn. National Acadamy of Clinical Biochemisry, 1998.</li><li><a class="nounderline abstract_t">Kesselman EJ, Figueroa R, Garry D, Maulik D. The usefulness of the TDx/TDxFLx fetal lung maturity II assay in the initial evaluation of fetal lung maturity. Am J Obstet Gynecol 2003; 188:1220.</a></li><li><a class="nounderline abstract_t">Hagen E, Link JC, Arias F. A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome. Obstet Gynecol 1993; 82:1004.</a></li><li><a class="nounderline abstract_t">Parvin CA, Kaplan LA, Chapman JF, et al. Predicting respiratory distress syndrome using gestational age and fetal lung maturity by fluorescent polarization. Am J Obstet Gynecol 2005; 192:199.</a></li><li><a class="nounderline abstract_t">Kaplan LA, Chapman JF, Bock JL, et al. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay. Clin Chim Acta 2002; 326:61.</a></li><li><a class="nounderline abstract_t">Kamath BD, Marcotte MP, DeFranco EA. Neonatal morbidity after documented fetal lung maturity in late preterm and early term infants. Am J Obstet Gynecol 2011; 204:518.e1.</a></li><li><a class="nounderline abstract_t">Carlan SJ, Gearity D, O'Brien WF. The effect of maternal blood contamination on the TDx-FLM II assay. Am J Perinatol 1997; 14:491.</a></li><li><a class="nounderline abstract_t">Albright TS, Colombo DF, Euscher E, Samuels P. Evaluation of the effect of meconium on assessment of fetal lung maturity status by TDxFLM II testing. Obstet Gynecol 2004; 104:952.</a></li><li><a class="nounderline abstract_t">Wong SS, Schenkel O, Qutishat A. Strategic utilization of fetal lung maturity tests. Scand J Clin Lab Invest 1996; 56:525.</a></li><li><a class="nounderline abstract_t">Srouji SS, Carr DB, Gardella CM, et al. The effect of common clinical contaminants on amniotic fluid fluorescence polarization results. Obstet Gynecol 2004; 104:1237.</a></li><li><a class="nounderline abstract_t">Grenache DG, Parvin CA, Gronowski AM. Preanalytical factors that influence the Abbott TDx Fetal Lung Maturity II assay. Clin Chem 2003; 49:935.</a></li><li><a class="nounderline abstract_t">Spillman T, Cotton DB. Current perspectives in assessment of fetal pulmonary surfactant status with amniotic fluid. Crit Rev Clin Lab Sci 1989; 27:341.</a></li><li class="breakAll">Jobe AH. Fetal lung development, tests for maturation, induction of maturation and treatment. In: Maternal-Fetal Medicine, Creasy RK, Resnik R (Eds), WB Saunders, Philadelphia 1999. p.417.</li><li><a class="nounderline abstract_t">Piazze JJ, Maranghi L, Cosmi EV, Anceschi MM. The effect of polyhydramnios and oligohydramnios on fetal lung maturity indexes. Am J Perinatol 1998; 15:249.</a></li><li><a class="nounderline abstract_t">Wijnberger LD, de Kleine M, Voorbij HA, et al. The effect of clinical characteristics on the lecithin/sphingomyelin ratio and lamellar body count: a cross-sectional study. J Matern Fetal Neonatal Med 2003; 14:373.</a></li><li><a class="nounderline abstract_t">Dombroski RA, MacKenna J, Brame RG. Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens. Am J Obstet Gynecol 1981; 140:461.</a></li><li><a class="nounderline abstract_t">Lambers DS, Brady K, Leist PA, et al. Ability of normal vaginal flora to produce detectable phosphatidylglycerol in amniotic fluid in vitro. Obstet Gynecol 1995; 85:651.</a></li><li><a class="nounderline abstract_t">Schumacher RE, Parisi VM, Steady HM, Tsao FH. Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid. Am J Obstet Gynecol 1985; 151:1067.</a></li><li><a class="nounderline abstract_t">Tanasijevic MJ, Winkelman JW, Wybenga DR, et al. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests. Am J Clin Pathol 1996; 105:17.</a></li><li><a class="nounderline abstract_t">Livingston EG, Herbert WN, Hage ML, et al. Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. The Diabetes and Fetal Maturity Study Group. Obstet Gynecol 1995; 86:826.</a></li><li><a class="nounderline abstract_t">Curet LB, Tsao FH, Zachman RD, et al. Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies. Int J Gynaecol Obstet 1989; 30:105.</a></li><li><a class="nounderline abstract_t">Berkowitz K, Reyes C, Saadat P, Kjos SL. Fetal lung maturation. Comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med 1997; 42:793.</a></li><li><a class="nounderline abstract_t">Melanson SE, Jarolim P, McElrath TF. Fetal lung maturity testing in diabetic mothers. Lab Med 2007; 38:553.</a></li><li><a class="nounderline abstract_t">Leveno KJ, Quirk JG, Whalley PJ, et al. Fetal lung maturation in twin gestation. Am J Obstet Gynecol 1984; 148:405.</a></li><li><a class="nounderline abstract_t">Mackenzie MW. Predicting concordance of biochemical lung maturity in the preterm twin gestation. J Matern Fetal Neonatal Med 2002; 12:50.</a></li><li><a class="nounderline abstract_t">Whitworth NS, Magann EF, Morrison JC. Evaluation of fetal lung maturity in diamniotic twins. Am J Obstet Gynecol 1999; 180:1438.</a></li><li><a class="nounderline abstract_t">Ahmed B, Konje JC. Fetal lung maturity assessment: A historic perspective and Non - invasive assessment using an automatic quantitative ultrasound analysis (a potentially useful clinical tool). Eur J Obstet Gynecol Reprod Biol 2021; 258:343.</a></li><li><a class="nounderline abstract_t">Prayer F, Watzenböck ML, Heidinger BH, et al. Fetal MRI radiomics: non-invasive and reproducible quantification of human lung maturity. Eur Radiol 2023; 33:4205.</a></li><li><a class="nounderline abstract_t">Zamarian ACP, Caetano ACR, Grohmann RM, et al. Prediction of Lung Maturity in Fetuses with Growth Restriction through Quantitative Ultrasound Analysis. Ultrasound Med Biol 2022; 48:20.</a></li><li><a class="nounderline abstract_t">Tang Y, Jin XD, Xu L, et al. The Value of Ultrasonography in Assessing Fetal Lung Maturity. J Comput Assist Tomogr 2020; 44:328.</a></li><li><a class="nounderline abstract_t">Moradi B, Ghorbani Z, Shirazi M, et al. Comparison of fetal lung maturation in fetuses with intrauterine growth restriction with control group, using lung volume, lung/liver and lung/muscle signal intensity and apparent diffusion coefficient ratios on different magnetic resonance imaging sequences. J Matern Fetal Neonatal Med 2022; 35:8936.</a></li><li><a class="nounderline abstract_t">Moreno-Espinosa AL, Hawkins-Villarreal A, Coronado-Gutierrez D, et al. Prediction of Neonatal Respiratory Morbidity Assessed by Quantitative Ultrasound Lung Texture Analysis in Twin Pregnancies. J Clin Med 2022; 11.</a></li><li><a class="nounderline abstract_t">Rabachini Caetano AC, Machado Nardozza LM, Perez Zamarian AC, et al. Prediction of lung maturity through quantitative ultrasound analysis of fetal lung texture in women with diabetes during pregnancy. J Perinat Med 2023; 51:913.</a></li></ol></div><div id="topicVersionRevision">Topic 405 Version 34.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22222548" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Increased risk for respiratory distress among white, male, late preterm and term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10489844" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27399933" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18757686" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : ACOG Practice Bulletin No. 97: Fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24139938" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The case for amniocentesis for fetal lung maturity in late-preterm and early-term gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28225423" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Committee Opinion No. 688: Management of Suboptimally Dated Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21099593" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Neonatal outcomes after demonstrated fetal lung maturity before 39 weeks of gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29800541" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Neonatal outcomes of elective early-term births after demonstrated fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19623003" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : ACOG Practice Bulletin No. 107: Induction of labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11165600" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16150274" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Comparison of the TDx-FLM II and lecithin to sphingomyelin ratio assays in predicting fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17074687" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A direct comparison between lamellar body counts and fluorescent polarization methods for predicting respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16260210" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11165603" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Lamellar body counts: a consensus on protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16598293" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Changes in the threshold of fetal lung maturity testing and neonatal outcome of infants delivered electively before 39 weeks gestation: implications and cost-effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16147729" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Amniotic fluid lamellar body count and its sensitivity and specificity in evaluating of fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7617355" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Amniotic fluid lamellar body count: a rapid and reliable fetal lung maturity test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15221326" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non-diabetic pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19529999" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Determining a cutoff for fetal lung maturity with lamellar body count testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23570861" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Predicting respiratory distress syndrome using gestational age and lamellar body count.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11426891" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The accuracy of lamellar body count and lecithin/sphingomyelin ratio in the prediction of neonatal respiratory distress syndrome: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23481577" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Lecithin/sphingomyelin ratio and lamellar body count for fetal lung maturity: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/180804" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16303123" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4017245" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Three methods compared for determining phosphatidylglycerol in amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3838619" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Laboratory and clinical evaluation of a rapid slide agglutination test for phosphatidylglycerol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2646906" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Phosphatidylglycerol in amniotic fluid. Comparison of an "ultrasensitive" immunologic assay with TLC and enzymatic assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6733906" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Evaluation of the Amniostat-FLM assay for assessment of fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4000572" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Standard lecithin/sphingomyelin and phosphatidylglycerol techniques compared with immunologic slide test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8990255" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8990255" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4602156" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The interpretation and significance of the lecithin-sphingomyelin ratio in amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1595605" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The laboratory assessment of fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5067186" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/581610" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Assessing fetal lung maturation by the foam stability index test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/581610" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Assessing fetal lung maturation by the foam stability index test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8792602" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8792602" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12748484" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The usefulness of the TDx/TDxFLx fetal lung maturity II assay in the initial evaluation of fetal lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8233250" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15672025" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Predicting respiratory distress syndrome using gestational age and fetal lung maturity by fluorescent polarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12417097" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21752754" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Neonatal morbidity after documented fetal lung maturity in late preterm and early term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9376013" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The effect of maternal blood contamination on the TDx-FLM II assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15516384" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Evaluation of the effect of meconium on assessment of fetal lung maturity status by TDxFLM II testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8903114" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Strategic utilization of fetal lung maturity tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15572483" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The effect of common clinical contaminants on amniotic fluid fluorescence polarization results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12765990" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Preanalytical factors that influence the Abbott TDx Fetal Lung Maturity II assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2675912" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Current perspectives in assessment of fetal pulmonary surfactant status with amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2675912" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Current perspectives in assessment of fetal pulmonary surfactant status with amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9565223" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The effect of polyhydramnios and oligohydramnios on fetal lung maturity indexes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15061315" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The effect of clinical characteristics on the lecithin/sphingomyelin ratio and lamellar body count: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6894668" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7724090" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Ability of normal vaginal flora to produce detectable phosphatidylglycerol in amniotic fluid in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3885741" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8561082" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7566857" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. The Diabetes and Fetal Maturity Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2572479" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9437594" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Fetal lung maturation. Comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Fetal lung maturity testing in diabetic mothers</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6695997" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Fetal lung maturation in twin gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12422910" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Predicting concordance of biochemical lung maturity in the preterm twin gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10368484" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Evaluation of fetal lung maturity in diamniotic twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33529970" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Fetal lung maturity assessment: A historic perspective and Non - invasive assessment using an automatic quantitative ultrasound analysis (a potentially useful clinical tool).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36604329" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Fetal MRI radiomics: non-invasive and reproducible quantification of human lung maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34607759" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Prediction of Lung Maturity in Fetuses with Growth Restriction through Quantitative Ultrasound Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32345806" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The Value of Ultrasonography in Assessing Fetal Lung Maturity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34847801" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Comparison of fetal lung maturation in fetuses with intrauterine growth restriction with control group, using lung volume, lung/liver and lung/muscle signal intensity and apparent diffusion coefficient ratios on different magnetic resonance imaging sequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36013134" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prediction of Neonatal Respiratory Morbidity Assessed by Quantitative Ultrasound Lung Texture Analysis in Twin Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37097317" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prediction of lung maturity through quantitative ultrasound analysis of fetal lung texture in women with diabetes during pregnancy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
